RadNet, Inc. (RDNT)
NASDAQ: RDNT · Real-Time Price · USD
82.51
+0.35 (0.43%)
Nov 21, 2024, 2:08 PM EST - Market open
RadNet Revenue
RadNet had revenue of $461.14M in the quarter ending September 30, 2024, with 14.72% growth. This brings the company's revenue in the last twelve months to $1.77B, up 12.20% year-over-year. In the year 2023, RadNet had annual revenue of $1.62B with 13.05% growth.
Revenue (ttm)
$1.77B
Revenue Growth
+12.20%
P/S Ratio
3.31
Revenue / Employee
$210,040
Employees
8,441
Market Cap
6.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.62B | 186.57M | 13.05% |
| Dec 31, 2022 | 1.43B | 105.87M | 8.00% |
| Dec 31, 2021 | 1.32B | 226.08M | 20.59% |
| Dec 31, 2020 | 1.10B | -56.08M | -4.86% |
| Dec 31, 2019 | 1.15B | 179.03M | 18.36% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.45B |
| R1 RCM | 2.46B |
| Lantheus Holdings | 1.50B |
| Merit Medical Systems | 1.33B |
| Halozyme Therapeutics | 947.36M |
| Corcept Therapeutics | 628.56M |
| Blueprint Medicines | 434.42M |
| Cytokinetics | 3.22M |
RDNT News
- 9 days ago - RadNet, Inc. (RDNT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™ - Business Wire
- 10 days ago - RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA⁽¹⁾ and Revises Upwards 2024 Financial Guidance Ranges - GlobeNewsWire
- 27 days ago - RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 7 weeks ago - RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects - Seeking Alpha
- 2 months ago - RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th - GlobeNewsWire
- 2 months ago - RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division - GlobeNewsWire
- 2 months ago - RadNet's DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare - GlobeNewsWire